The Complete Wegovy vs Mounjaro Comparison Guide
Which Is Better Mounjaro or Wegovy: Understanding Key Mechanisms
When comparing which is better Mounjaro or Wegovy, the fundamental difference lies in how each prescription-only medicine works. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone to reduce appetite and promote satiety after smaller meals. Mounjaro uses tirzepatide, which targets both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptors simultaneously, creating a dual agonist approach to weight management.
This mechanistic difference means each medication may work differently for individual patients, which is why the question of which is better Mounjaro or Wegovy doesn't have a universal answer. Your body's response to GLP-1 alone versus the dual receptor approach depends on your unique physiology, medical history, and weight management goals. Both medications must be prescribed alongside a reduced-calorie diet and increased physical activity, and both require careful dose escalation under medical supervision.
Wegovy vs Mounjaro Pricing: Complete Cost Comparison
Understanding the cost structure can help determine which is better Mounjaro or Wegovy for your budget. Wegovy pricing starts at £79.99 for the 0.25mg starter dose (after applying discount code FIRST40 for new customers), progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. Our bundle options provide convenient multi-month supplies, such as the Intro Trio (0.25mg, 0.5mg, 1mg) for £299.99, ensuring consistent treatment progression.
Mounjaro follows a different pricing structure with six dose levels from 2.5mg to 15mg, each requiring careful titration. Both medications are available through EverydayMeds with the same professional prescriber review process and next-day cold-chain delivery. Returning customers can use code DOSE25 at checkout, while new patients benefit from FIRST40 pricing. The total treatment cost depends on your maintenance dose and treatment duration, making individual consultation essential for accurate budgeting.
Clinical Evidence: Wegovy vs Mounjaro Research Data
When evaluating which is better Mounjaro or Wegovy, clinical trial data provides important context, though direct head-to-head comparisons aren't available. Wegovy's STEP trials demonstrated significant weight management results, with STEP 1 showing approximately 15% average weight loss at 68 weeks when used alongside diet and exercise, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial showed a 20% reduction in major cardiovascular events.
Mounjaro's SURMOUNT trials showed its own impressive results using different trial designs and patient populations, making direct percentage comparisons inappropriate. Both medications underwent rigorous MHRA approval processes and carry the black triangle symbol (▼) indicating additional monitoring. Your prescriber can help interpret how these clinical findings might apply to your individual circumstances when determining which treatment approach may be most suitable.
How Wegovy Works: The GLP-1 Advantage
Wegovy's mechanism centres on GLP-1 receptor activation, which occurs naturally when you eat but diminishes quickly in normal physiology. By providing sustained GLP-1 activity through weekly injections, Wegovy may help reduce appetite, increase feelings of fullness after meals, and potentially decrease food cravings by working on brain appetite centres. The medication uses Novo Nordisk's FlexTouch pen technology, designed for once-weekly self-administration with pre-filled, colour-coded pens for each dose strength. The mandatory dose escalation schedule—starting at 0.25mg and gradually increasing to 2.4mg maintenance over 16 weeks—helps minimise gastrointestinal side effects while optimising therapeutic benefits. This gradual approach allows your body to adapt to the medication's effects, improving tolerability and treatment adherence.
EverydayMeds Ordering Process: Simple and Secure
Accessing either Wegovy or Mounjaro through EverydayMeds follows the same streamlined process, regardless of which option you and your prescriber determine is most suitable. The journey begins with a comprehensive 3-minute online clinical assessment covering your medical history, current medications, weight management goals, and any contraindications. Our qualified prescribers review your application within 3 working days (or 24 hours with express service), ensuring thorough evaluation of your suitability for treatment. Once approved, your medication ships via next-day delivery using specialised cold-chain packaging to maintain the 2-8°C temperature requirements. Our GPhC-registered pharmacy (#9012878) ensures all medications meet strict UK quality standards. You'll receive detailed injection guidance, dose escalation schedules, and ongoing support throughout your treatment journey.
Storage and Practical Considerations: Wegovy vs Mounjaro
Storage requirements often influence treatment choice when considering which is better Mounjaro or Wegovy for your lifestyle. Wegovy offers superior travel convenience, maintaining potency for up to 6 weeks at room temperature (below 30°C) once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both medications require refrigeration at 2-8°C before first use and should never be frozen or exposed to direct sunlight. Wegovy's FlexTouch pen system provides clear dose display and reliable injection mechanics, while the colour-coded pen caps (white for 0.25mg, green for 0.5mg, etc.) help prevent dosing errors. The once-weekly injection schedule suits busy lifestyles better than daily medications, and the prefilled pens eliminate complex preparation procedures. Proper disposal through pharmacy return schemes ensures environmental responsibility and medication security.
Dual Mechanism vs Single Target: Which Is Better for Your Goals?
The question of which is better Mounjaro or Wegovy ultimately depends on how your body responds to different hormonal pathways. Wegovy's focused GLP-1 approach provides proven efficacy with well-established side effect profiles and extensive real-world usage data. Some patients prefer this targeted mechanism, particularly if they respond well to GLP-1 activity or have specific medical considerations that favour single-receptor targeting.
Mounjaro's dual GIP and GLP-1 activation offers a different approach that may suit patients who need broader hormonal influence on weight management. However, dual mechanisms can also mean more complex side effect considerations and potentially different contraindication profiles. Your prescriber's expertise becomes crucial in weighing these factors against your individual medical history, treatment goals, and tolerance considerations.
Making Your Choice: Both Available from EverydayMeds
Rather than declaring which is better Mounjaro or Wegovy, EverydayMeds provides access to both options with expert prescriber guidance to help you choose. Our clinical team evaluates your complete medical profile, lifestyle factors, budget considerations, and treatment preferences to recommend the most appropriate option. You can start your assessment today using discount codes FIRST40 (new customers) or DOSE25 (returning patients) at checkout, with medications available from £79.99 for Wegovy starter doses. The decision ultimately rests with you and your healthcare provider, supported by our comprehensive clinical assessment process and ongoing treatment monitoring. Visit https://everydaymeds.co.uk/collections/weight-loss to begin your evaluation and discover which prescription-only medicine aligns best with your weight management goals. Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
